Ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema (RESTORE)


April 1, 2011

Clinical trial

The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

Mitchell P, Bandello F, Schmidt-Erfurth U, Lang GE, Massin P, Schlingemann RO, Sutter F, Simader C, Burian G, Gerstner O, Weichselberger A.

Ophthalmology. 2011 Apr;118(4):615-25
Full text | Metrics.

May 1, 2014

Clinical trial

Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study.

Schmidt-Erfurth U, Lang GE, Holz FG, Schlingemann RO, Lanzetta P, Massin P, Gerstner O, Bouazza AS, Shen H, Osborne A, Mitchell P.

Ophthalmology. 2014 May;121(5):1045-53.
Full text | Metrics.

Share This Article :

Source Archive